Welcome to our dedicated page for Rocket Doctor AI news (Ticker: AIRDF), a resource for investors and traders seeking the latest updates and insights on Rocket Doctor AI stock.
Rocket Doctor AI Inc. reports developments tied to its physician-led, AI-powered healthcare technology business and its wholly owned Rocket Doctor Inc. digital health platform and marketplace. Company news commonly covers U.S. payer network agreements, state-by-state access expansion, physician services delivered through the platform, and updates to primary care, chronic disease management, preventive care, virtual urgent care, and specialist coordination.
Recurring announcements also address financial results, product and engineering capacity, equity-based compensation, clinical AI initiatives, and the Global Library of Medicine decision support system. The company’s completed acquisition of Alea Health Holdings Ltd. adds conversational AI-powered mental health capabilities to its healthcare technology profile.
Rocket Doctor AI (OTC: AIRDF) reported that holders exercised a total of 3,414,896 common share purchase warrants at $0.60, generating aggregate gross proceeds of approximately CAD$2,048,938 through March 13, 2026.
Of those, 2,054,224 warrants were exercised in the prior three months, producing about CAD$1,232,535. The company said proceeds will be used for working capital and general corporate purposes as it pursues North American AI healthcare expansion and 2026 U.S. growth plans.
Rocket Doctor AI (OTC: AIRDF) announced an in-network agreement with a major New York insurer adding approximately 20,000 Medicare Advantage and D-SNP members, effective April 1, 2026. This builds on a March 3, 2026 expansion of ~2.4 million members and brings total in-network reach to over 15 million covered lives nationwide. The agreement enables eligible New York members to access board-certified physicians via Rocket Doctor’s digital health platform for primary care, chronic disease management, preventive services, and coordinated follow-up, pending credentialing and plan eligibility.
Rocket Doctor (OTC:AIRDF) signed an in-network agreement with a major New York insurer covering more than 2.4 million members, expanding access across Medicaid Managed Care, HARP, Medicare Advantage/D-SNP, Managed Long-Term Care, and individual plans.
The deal increases Rocket Doctor’s total in-network reach to over 15 million covered lives across key U.S. markets, reinforcing rapid payer network expansion and broader access to digital medical and behavioral health services in New York.
Rocket Doctor AI (OTC:AIRDF) and Lethbridge County launched a partnership on Feb 24, 2026 to expand Alberta Health–covered virtual primary and urgent care with no user fees. The agreement launches today, automatically renewing for subsequent two-year periods on identical terms.
The county-specific service gives residents secure virtual access to licensed Alberta physicians for urgent care, chronic condition management, primary care and mental health, and aims to address rural physician shortages.
Rocket Doctor reported serving 16,417 patients in Q3 2025, up from 9,090 in Q3 2024 (an 81% YoY increase).
Rocket Doctor AI (OTC: AIRDF) engaged Danayi Capital for a two-month digital marketing contract starting Feb 9, 2026 for an up-front fee of USD 125,000. Danayi will run online advertising via wallstreetlogic.com and holds no current interest in the company.
The company also granted 33,353 stock options exercisable at $0.77 for three years and 205,065 restricted share units valid for three years; both awards vest over one year and are issued under the company’s share compensation plans.
Rocket Doctor (OTC:AIRDF) signed an agreement with a major U.S. commercial insurer to add approximately 175,000 eligible members in California to its in-network physician marketplace. The addition increases Rocket Doctor’s total in-network reach to well over 13 million covered lives across key U.S. markets (primarily California and New York). The contract covers employer-sponsored health plans in California and positions the company to strengthen its payer mix, support clinician-led access to care, and pursue sustained U.S. revenue growth while complying with applicable California benefit and regulatory requirements.
Rocket Doctor AI (OTC: AIRDF) announced grants of equity awards to consultants on January 12, 2026. The company granted an aggregate 75,000 stock options exercisable at $0.74 per share for a three‑year term and 212,148 restricted share units (RSUs) with a three‑year term. All awards vest over one year and are issued under the company’s share compensation plans.
Rocket Doctor AI (OTC: AIRDF) closed its acquisition of Alea Health on Jan 8, 2026, under a definitive share purchase agreement dated Nov 19, 2025, as amended Dec 31, 2025.
The consideration included a US $15,000 acquisition deposit previously paid in cash, issuance of 285,712 common shares at a deemed CAD $0.70 per share, and assumption of a US $180,000 SAFE note to be paid in equal monthly installments of US $22,500, with the first installment paid at closing.
Consideration shares were issued under prospectus exemptions, are subject to a statutory hold period of four months and one day, and a 28-month escrow schedule releasing 20% every four months beginning on the first anniversary. No finder’s fees were paid and no long-term liabilities were assumed other than the SAFE note.
Rocket Doctor AI (OTC:AIRDF) announced a partnership with the CAN Health Network and Health Cities to pilot an AI-powered Clinical Decision Support System (CDSS) in Alberta.
The pilot runs from November 2025 to March 2026, will deploy at up to four primary care sites with about 20 clinicians, and phases include chatbot intake, real-time clinician support, and EMR integration. The company cites an expected 25–40% reduction in intake time, Canadian-hosted data centres compliant with HIPAA, PIPEDA, and Alberta HIA, and a Commercialization Project Agreement dated 11/12/2025. The project aims to validate CDSS performance and potentially scale across Alberta’s ~4,400 providers.
Rocket Doctor AI (CSE: AIDR | OTC: AIRDF) announced a management change and equity awards on Dec 5, 2025. Effective Dec 8, 2025, Christopher Cherry will become Interim Chief Financial Officer, replacing David Worner; Mr. Cherry currently serves as Chair of the Audit Committee.
The company granted an aggregate 579,028 stock options exercisable at $0.84 per share with terms of three or five years, and 931,112 restricted share units with terms of two to five years, to executives, directors and consultants. Awards are issued under the company’s share compensation plans and are subject to vesting conditions.